An2 Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in An2 Therapeutics by Balyasny Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $395k | 19k | 20.49 |